Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ARG A 160GLU A 275GLU A 276TYR A 669VAL A 781TYR A 787TYR A 791ASN A 835VAL A 836HIS A 865
None
0.63A
1x70A-6eotA:undetectable
1x70A-6eotA:7.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ILE A 6ALA A 8MET A 21LEU A 29PHE A 32THR A 47ILE A 51LEU A 55ILE A 96TYR A 102
MTX A 164 (-4.0A)MTX A 164 ( 3.7A)MTX A 164 (-3.3A)MTX A 164 (-4.0A)MTX A 164 (-4.1A)NDP A 163 (-3.4A)MTX A 164 (-4.1A)MTX A 164 ( 4.4A)MTX A 164 ( 4.2A)None
0.48A
4pssA-3ia4A:undetectable
4pssA-3ia4A:55.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
ALA A 8MET A 21LEU A 29PHE A 32LYS A 33THR A 47ILE A 51ILE A 96TYR A 102THR A 115
MTX A 164 ( 3.7A)MTX A 164 (-3.3A)MTX A 164 (-4.0A)MTX A 164 (-4.1A)MTX A 164 (-3.2A)NDP A 163 (-3.4A)MTX A 164 (-4.1A)MTX A 164 ( 4.2A)NoneMTX A 164 (-4.3A)
0.47A
4pstA-3ia4A:undetectable
4pstA-3ia4A:55.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
ALA A 8MET A 21LEU A 29PHE A 32THR A 47ILE A 51LEU A 55ILE A 96TYR A 102THR A 115
MTX A 164 ( 3.7A)MTX A 164 (-3.3A)MTX A 164 (-4.0A)MTX A 164 (-4.1A)NDP A 163 (-3.4A)MTX A 164 (-4.1A)MTX A 164 ( 4.4A)MTX A 164 ( 4.2A)NoneMTX A 164 (-4.3A)
0.44A
4pstA-3ia4A:undetectable
4pstA-3ia4A:55.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
ASN Z 351PRO Z 352HIS Z 353GLU Z 377HIS Z 378SER Z 379TRP Z 380TRP Z 386PHE Z 402GLY X 575
85C Z 502 (-3.6A)85C Z 502 (-4.4A)85C Z 502 (-3.9A)85C Z 502 (-3.2A)85C Z 502 (-3.8A)85C Z 502 (-3.2A)85C Z 502 (-3.2A)85C Z 502 (-3.4A)None85C Z 502 (-3.7A)
0.59A
5fqdE-5hxbZ:51.45fqdF-5hxbZ:undetectable
5fqdE-5hxbZ:99.265fqdF-5hxbZ:21.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
ASN Z 351PRO Z 352HIS Z 353HIS Z 378SER Z 379TRP Z 380TRP Z 386TRP Z 400PHE Z 402GLY X 575
85C Z 502 (-3.6A)85C Z 502 (-4.4A)85C Z 502 (-3.9A)85C Z 502 (-3.8A)85C Z 502 (-3.2A)85C Z 502 (-3.2A)85C Z 502 (-3.4A)85C Z 502 (-3.7A)None85C Z 502 (-3.7A)
0.39A
5fqdE-5hxbZ:51.45fqdF-5hxbZ:undetectable
5fqdE-5hxbZ:99.265fqdF-5hxbZ:21.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
ASN Z 351PRO Z 352HIS Z 353GLU Z 377HIS Z 378TRP Z 380TRP Z 386TRP Z 400PHE Z 402GLY X 575
85C Z 502 (-3.6A)85C Z 502 (-4.4A)85C Z 502 (-3.9A)85C Z 502 (-3.2A)85C Z 502 (-3.8A)85C Z 502 (-3.2A)85C Z 502 (-3.4A)85C Z 502 (-3.7A)None85C Z 502 (-3.7A)
0.60A
6h0gB-5hxbZ:51.96h0gC-5hxbZ:undetectable
6h0gB-5hxbZ:62.906h0gC-5hxbZ:10.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.